Holding(s) in Company

Summary by AI BETAClose X

David John Smith has increased his holding in Hemogenyx Pharmaceuticals PLC, crossing a notification threshold on January 6, 2026. His total voting rights now stand at 7.762%, representing 468,923 voting rights, up from a previous notification of 6.750640%. This increase is attributed to direct voting rights of 211,976 and indirect voting rights of 256,947, with no holdings through financial instruments.

Disclaimer*

UK 100

Latest directors dealings